Skip to cookie consent Skip to main content

Advancing patient-centered research and innovation

Research-infused care sets Mass General Brigham apart. Our researchers changing the world are also providing care. As a national leader in innovation, our patient-centered mentality and systemwide collaborative approach are the keys to research breakthroughs that drive medical innovation, gain new knowledge, and improve patient outcomes.

Our physician-scientists—in the lab, in the clinic, and at the bedside—work tirelessly to understand the effects of debilitating diseases and our patient’s needs to help guide our studies and improve patient care.

Over 200 years

of leading innovative science

3,700 clinical trials

currently ongoing

13 Nobel Laureates

for research achievements and medical firsts

Pushing the boundaries of discovery

As a world-recognized leader in research, we are home to one of the largest hospital system-based research medical centers in the U.S., with an annual research budget of nearly $2 billion. Here, our researchers and clinicians are conducting thousands of studies in every major medical therapeutic and technology discipline. We are currently enrolling our patients in over 3,700 ongoing clinical trials, including nearly 100 for COVID-19, to accelerate bringing new treatments and therapies to our patients and the world.

A legacy of medical innovation

Mass General Brigham is one of the nation’s leading research medical centers with several Harvard Medical School teaching hospitals. Research is a mainstay in our culture. A passion for learning, questioning, discovery, and furthering knowledge is part of our makeup.

The greatest minds at our research medical centers have a history of pushing the boundaries of medicine and leading innovative science for over 200 years. We have a legacy of medical achievement, with numerous medical firsts and 13 Nobel Laureates. 

Our location in the Massachusetts biotech and academic medical communities creates enhanced collaborations with partners from academia, industry, and venture capital to help stimulate the development of our discoveries into lifesaving therapies for our patients.

The next big breakthrough

Our Innovation team supports inventors, entrepreneurs, and thought-leaders in developing new products and technologies that benefit patients everywhere. These efforts improve patient outcomes and transform care. Companies around the world license and use our software, medical devices, diagnostics, and therapeutics. In addition, Mass General Brigham Ventures is an early-stage venture capital firm founded to advance new life science technologies emerging from our vast research network.

Gene and cell therapy

Researchers at Mass General Brigham are leaders in gene and cell therapies, translating to treatment for patients through clinical trials. We bring together 400 leading gene and cell therapy researchers from five nationally ranked academic medical centers with multidisciplinary expertise to accelerate innovation and ultimately improve patient care for a variety of congenital and non-congenital diseases.

DNA sample being pipetted into petri dish with DNA gel in background